Star Health & Allied Insurance Company Ltd

- There is a mention of new ESOP issuances planned, but these will be issued at market price and will not impact the profit and loss account significantly. (Page 6) - No explicit statement or indication of any current or future fundraising through debt or equity is provided in the transcript. - The company highlights a strong solvency ratio of 2.14 times, indicating a comfortable capital position without expressing any immediate need for raising capital. (Page 6 and 11) - Discussion around profitability and capital adequacy suggests the company is well-positioned financially, with plans to maintain healthy solvency and potentially pay dividends in the future after risk-based solvency implementation. (Page 11) - No announcements or indications regarding fresh equity or debt fundraises were made during the call.

- The transcript does not explicitly mention any specific current or future capex or capital investment plans. - It highlights ongoing strategic initiatives such as increasing exclusive agent numbers and expanding partnerships with large NBFCs. - There is focus on improving fraud control, negotiating hospital rates, and growing profitable business segments including retail and group insurance. - Investment strategy includes increasing exposure to ETFs from 4.1% to about 7% of the portfolio. - No direct mention of new technology capex; however, collaboration with a fintech firm on wellness programs integrating IoT devices into their app indicates a digital/technology focus. - ESOP issuances are planned at market price, which will not impact P&L. - Overall, emphasis is on profitable growth and operational efficiency rather than large capex or new strategic investment announcements in this transcript.

- Star Health expects to grow faster than the health insurance industry, particularly in retail health. - April 2023 premium growth is promising, with over 25% growth expected for the month. - For FY2024, value growth is expected around 55%-60%, and volume growth around 40%-45%. - The company aims to improve average sum assured and target more affluent customer segments. - Market share in retail health is targeted to increase beyond FY2023 levels (currently at 34%). - Digital initiatives and partnerships with banks and corporate agents are expected to drive growth. - Agency strength is growing, with addition of exclusive agents aiming to double from last year’s ~18,000. - Inclusive growth across retail and group business with focus on profitable SME groups. - Continued focus on innovative and specialized health insurance products to drive growth momentum.

- Company expects to sustain faster than industry growth in retail health segment, with promising early FY2024 performance (April growth over 25%). - Combined operating ratio is expected to improve for FY2024, aided by price hikes, efficiency improvements, and technology-driven initiatives. - ROE guidance for FY2024 is targeted at 16%-18%, up from 12.4% in FY2023 (adjusted for ESOP costs). - Profit after tax for FY2023 was Rs. 619 crore (Rs. 768 crore excluding non-business costs); Q4 FY2023 PAT was Rs. 102 crore. - APAT growth is expected from continued premium hikes and profitable product mix shifts. - New product launches and expanded bancassurance tie-ups are expected to drive growth. - Price increases are ongoing, monitored by product loss ratios, to maintain profitability. - Growth strategies focus on profitable segments, including SME groups and higher sum assured products, supporting sustainable earnings expansion.

The provided transcript pages from the Star Health and Allied Insurance Company Limited earnings call do not contain information related to the company's current or expected order book or pending orders. The discussion primarily focuses on financial performance, growth strategies, agent additions, hospital network agreements, fraud management initiatives, product mix, and operational metrics. Therefore, no details on current or expected order books or pending orders are available in the provided document pages.